CONTENT CENTER

Issues in Chinese Foreign Direct Investment in U.S. Early Stage Biotechnology Companies
Raise Capital, Articles Guest Contributor Raise Capital, Articles Guest Contributor

Issues in Chinese Foreign Direct Investment in U.S. Early Stage Biotechnology Companies

By Flora Brookfield

There has been a marked increase in the amount of money being invested by Chinese investors into U.S. early stage biotechnology companies since 2017, spurred on by direct encouragement from Beijing through its Made in China 2025 industrial policy, which specifically targets biotech as a strategic industry eligible for greater government backing. In the first half of 2018, Chinese venture capital funds and high net worth family offices invested $5.1 billion in US biotech companies, exceeding the $4 billion invested by Chinese investors in all of 2017.

Read More

Sort by Topic:

Form a Company

Form a Company

Raise Capital

Build Your Team

Build Your Team

Protect Your Idea

Protect Your Idea and Data

Grow Your Company

Exits

Exits

View our full collection of blogs from Mintz by topic